| Pharmaceutical active ingredients: |
| FurosemidePenbutolol Sulfate |
| Available forms, composition and doses of Lasipressin: |
| N / A |
| Lasipressin medical category: |
| Human:Antihypertensive agentsDiuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03CA01 - FurosemideC07CA23 - Penbutolol and other diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Bristab | Furosemide; Hydroflumethiazide | Unidentified Pharmaceutical Company |
| Bristurin | Furosemide; Hydroflumethiazide | Unidentified Pharmaceutical Company |
| Di-Ademil | Furosemide; Hydroflumethiazide | Unidentified Pharmaceutical Company |
| Betasemid | Furosemide; Penbutolol Sulfate | Sanofi-Aventis; Dr. August Wolff Arzneimittel |
| Betasemid Mild | Furosemide; Penbutolol Sulfate | Sanofi-Aventis; Dr. August Wolff Arzneimittel |
| Normotensin | Furosemide; Penbutolol Sulfate | Sanofi-Aventis |
| Diucontin-K | Furosemide; Potassium Chloride | Mundipharma |
| Diumid + K | Furosemide; Potassium Chloride | Mundipharma |
| Diumide-K | Furosemide; Potassium Chloride | Pascual Laboratories; Zuellig Pharma |
| Diumide-K Continus | Furosemide; Potassium Chloride | Mundipharma; Viatris |